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ABSTRACT
A comprehensive knowledge of all the factors
involved in splicing, both proteins and RNAs, and of
their interaction network is crucial for reaching a
better understanding of this process and its func-
tions. A large part of relevant information is buried
in the literature or collected in various different data-
bases. By hand-curated screenings of literature and
databases, we retrieved experimentally validated
data on 71 human RNA-binding splicing regulatory
proteins and organized them into a database called
‘SpliceAid-F’ (http://www.caspur.it/SpliceAidF/). For
each splicing factor (SF), the database reports its
functional domains, its protein and chemical intera-
ctors and its expression data. Furthermore, we
collected experimentally validated RNA–SF inter-
actions, including relevant information on the RNA-
binding sites, such as the genes where these sites
lie, their genomic coordinates, the splicing effects,
the experimental procedures used, as well as the
corresponding bibliographic references. We also
collected information from experiments showing
no RNA–SF binding, at least in the assayed
conditions.
In total, SpliceAid-F contains 4227 interactions,
2590 RNA-binding sites and 1141 ‘no-binding’ sites,
including information on cellular contexts and condi-
tions where binding was tested.
The data collected in SpliceAid-F can provide sig-
nificant information to explain an observed splicing
pattern as well as the effect of mutations in func-
tional regulatory elements.
INTRODUCTION
Pre-mRNA splicing is an essential nuclear process where
intronic sequences are identiﬁed and removed, joining the
ﬂanking exons to generate mature mRNAs, which can be
then translocated and translated in the cytoplasm. The
splicing reaction, which has been recently shown to be
also affected by the chromatin status (1), is catalyzed by
the spliceosome, a large (60S) RNA–protein molecule
(2) that interacts with RNA elements like the 50 and 30
splice sites (ss) deﬁning the exon/intron boundaries, the
polypyrimidine tract that aids in 30ss recognition and the
branch-point sequence.
Indeed, in pre-mRNAs, there might be many other
elements helping the deﬁnition of exon/intron boundaries,
but it is not yet fully known how the splicing machinery
selects the 50 and 30ss to be used. It has been shown how
the choice seems to be driven by other cis-acting elements
(3), which can be located within both exons and introns.
These regulatory sequences can be bound by many differ-
ent splicing regulatory proteins or ‘‘splicing factors’’
(SFs), interacting with each other and leading to
the precise deﬁnition of a sequence as exon or intron (4).
In other words, SFs decode the information in the
pre-mRNA sequence by recognizing RNA-binding
motifs. Mutagenesis experiments have highlighted that
splicing regulatory elements are scattered within the
entire pre-mRNA sequence, and any transcribed nucleo-
tide could be potentially involved in the generation of the
splicing patterns.
Nearly all human transcripts can yield several different
splicing isoforms owing to the competition among differ-
ent factors for the same binding sites. Moreover, some
alternative splicing forms are cell-speciﬁc, yielding differ-
ent protein isoforms in different cells (5–8). Therefore, it is
evident that knowledge of the RNA-binding speciﬁcity of
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the trans-acting SFs is essential for predicting their
binding activity and to fully understand splicing regula-
tory mechanisms.
The known binding sites of SFs are usually summarized
as consensus target sites, deﬁned by the most frequent
nucleotide found at each position of the sites. This descrip-
tion has clear limitations, and tools using this model
(9–12) yield poor binding position predictions (13). To
overcome this problem and reduce the false-positive
results, descriptors should be built taking advantage of
information from the full set of original binding sites,
and if possible also from sites experimentally shown not
to be bound by the SF.
An SF ‘no-binding’ site is deﬁned as a sequence element
for which the SF has been experimentally shown to have
no binding afﬁnity in one or more cellular contexts. In
contrast, an SF-binding site is a sequence element that
speciﬁcally binds the SF in at least one condition (e.g.
cell type, physiological status, etc.). Another useful piece
of information is then the binding speciﬁcity in different
cellular contexts (conditional-binding sites, Table 3), as it
is possible that the same motif may be bound or not by the
same SF in different conditions. A curated data collection
of validated binding and no-binding sites for a given
factor, complete with their cellular speciﬁcity, can be
thus of relevant interest, for example, to train a machine
learning algorithm to accurately discriminate and predict
binding sites for a given SF, or to assess which sequence
elements seem to be more important for SF binding.
Unfortunately, few data on binding sites and their speci-
ﬁcity are as yet available, whereas data on no-binding sites
have never been collected.
To better understand the splicing process and function,
it is important to shed light on the complex network of
interactions involving SFs and their RNA target sites.
This goal is made difﬁcult by the high number of
RNA-binding proteins, some of them still unknown, the
limited information about their functional features and
the fact that available information is fragmented in a
large number of papers. Therefore, it would be useful to
collect in a unique resource all available information
about SFs.
We previously introduced two databases, SpliceAid (14)
and SpliceAid 2 (15), consisting of RNA motifs bound by
SFs, together with an interface designed to detect the
presence of putative motifs in sequences submitted by
users.
Here we present SpliceAid-F, an exhaustive repository
of SFs including information on their expression, func-
tional domains, protein and chemical interactors and
RNA-binding and no-binding sites. Information of
binding sites includes the corresponding genes, their
genomic coordinates, the splicing effect, the experi-
mental procedures used to assess binding and the
related references. All these data have been manually
extracted and collected by extensive database and
literature screenings, yielding information on 71 splicing
proteins, all those investigated so far to our knowledge
for which some information is available on their RNA
targets.
DATABASE DESIGN AND IMPLEMENTATION
Database structure description
SpliceAid-F contains information on human SFs,
organized in a relational database structured in four
tables. In the main table, SFs are listed together with
data concerning both the gene encoding the SF protein
and the protein itself. In particular, we collected ofﬁcial
gene symbols, their synonyms, NCBI Gene IDs and their
links to NCBI HomoloGene. Regarding proteins, the
databases lists the UniProt IDs, the type of RNA-
binding domains and the known interacting proteins
according to IntAct (16), STRING (17), DIP (18),
MINT (19), HPRD (7) and BioGRID (20) databases
and the interacting chemicals according to IntAct (16),
STITCH (17) and ProtChemSI (21). Also, the interface
reports the diseases associated with the alterations of SF
expression or mutations in the encoding gene (provided by
OMIM database), links to expression databases (Cancer
Genome Anatomy Project, Human Protein Atlas, Human
Protein Reference Database, Human Proteinpedia) and
CLIP (Crosslinking and ImmunoPrecipitation) data.
Each record in the main table corresponds to an SF,
and it is linked to records of the second and third tables,
collecting more data. In particular, the second table
contains the known RNA-binding sites for the SF, while
the third lists the SF no-binding sites. We also collected
experimental information on human SF binding to RNAs
from other species (listed in Supplementary Table S1),
including viruses using splicing machinery of the host cell.
For each binding site, we collected the species it belongs
to, its genomic coordinates and the corresponding gene.
The database also collects the experimental procedures
used to assess the binding and the cell or tissue
investigated, the splicing activity (in terms of exon deﬁn-
ition or intron deﬁnition) of the SF and the diseases
possibly associated with a binding site alteration
(provided by OMIM). Finally, the fourth table of
database stores, for each SF-binding or no-binding site,
the related literature references.
Protein annotation
Overall, the database contains data on 71 human SFs,
including 13 SR proteins, 27 heterogeneous nuclear
ribonucleoprotein (hnRNP) proteins and other 31
proteins belonging to the ELAV, KHDRBS, CELF,
Nova and Fox families. SR and hnRNP proteins mainly
host one or more RNA recognition motif (RRM)
domains, whereas other splicing proteins contain different
RNA-binding domains other than RRM, such as
K-homology domains, zinc ﬁngers and others (Table 1).
Concerning chemical interactions, we performed a
hand-curated ﬁltering of the data to include in the
database only the true interactors for each of the 71
splicing proteins. In fact, many interactions reported
in STITCH and IntAct seemed to be inaccurate.
For example, CUGBP1 (22), FMRP (23), hnRNP E2
(24–26) and SAP155 (27) do not interact with selenome-
thionine, but this modiﬁed amino acid is incorporated by
researchers instead of methionine to aid the structure
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elucidation of proteins by X-ray crystallography. FMRP
does not interact with magnesium, which is instead used in
the crystallization buffer (23). Analogously, we have per-
formed a literature screening to annotate only direct
protein–protein interactions. Also in this case, we found
several inaccuracies. For example, the interaction between
ZRANB2 and USP39, annotated by IntAct and
BioGRID, is not correct because the cited article (28)
shows instead the interaction between ZRANB1 and
USP39. A cautionary note is necessary for RNA binding
sited detected by Cross Linking and ImmunoPrecipitation
followed by high-throughput sequencing (CLIP-Seq) as
this technique may also support several false positive
binding sites (29).
RNA interaction annotations
RNA-binding data in SpliceAid-F is partly derived from
our previous SpliceAid database (14) and partly retrieved
from literature. For all binding and no-binding evidence
found in literature, we report the assays and the condi-
tions used by the authors. It should be taken into account
that a no-binding observation for a particular SF refers to
a speciﬁc context; therefore, the SF may bind the same
element in a different condition.
Different experimental techniques have been used for
the binding assessment, like EMSA, UV cross-linking
and immunoprecipitation, protein afﬁnity puriﬁcation,
pull-down assay, complementation assay, SELEX, ﬁlter-
binding assay, homopolymer-binding assay, nuclear
magnetic resonance methods, ﬂuorescence methods,
yeast three-hybrid assay and biosensor analysis. These
pieces of information allow the user to evaluate the reli-
ability of each RNA–protein interaction collected in
SpliceAid-F. For example, the user may consider not-
reliable-enough binding observations assessed only by
EMSA or by ﬁlter-binding assays with puriﬁed proteins,
as these are in vitro assays. In contrast, the binding might
be considered to be detected in a more reliable way when
UV cross-linking followed by immunoprecipitation or
additional assays, as small interfering RNA (siRNA)
silencing or complementation assay, is performed.
For multiple-sequence experiments, as SELEX, we con-
sidered each identiﬁed binding sequence and not the con-
sensus motif deduced by the authors. However, because
these sequences are usually much longer than the real
binding site, for each of these, we report only the motif
that the authors showed to be functional. This is usually
performed by identifying the functional motifs through
alignment of the binding sequences, followed by further
assays such as, for example, mutagenesis and immuno-
blotting. Similarly, in case of single-sequence experiments,
we followed the author’s assessments about the position
and the length of the functional motif to be annotated.
Moreover, we associated with each binding site a
normalized score, derived by the binding afﬁnity
deduced from the experiments. The score is computed ac-
cording to the criteria we previously introduced (14).
Brieﬂy, a positive score (+1 . . .+10) is assigned to target
Table 1. RNA-binding proteins collected in SpliceAid-F, including information on their functional domains
Proteins RNA-binding domain
Class Name RRM KH Zinc ﬁnger Other
SRs SC35, SRp20, SRp38, SRp54, HTra2a, HTra2b1 1
9G8 1 1 CCHC
SF2/ASF, SRp30c, SRp40, SRp55, SRp75 2
SRm160 1 PWI
hnRNPs hnRNP C, C1, C2, G 1
hnRNP P 1 1 RanBP2
hnRNP A0, A1, A2/B1, A3, D, D0, DL, H3 2
hnRNP F, H1, H2, L, LL, M, Q 3
hnRNP I (PTB), nPTB 4
hnRNP E1, E2, J, K 3
hnRNP U 1 SAP
Others Fox-1, Fox-2 1
RBM25 1 1 PWI
DAZAP1, PSF, TDP43 2
RBM4 2 1 CCHC
RBM5 2 1 C2H2, 1 RanBP2 1 G-patch
CUG-BP1, ESRP1, ESRP2, ETR-3, HuB, HuC,
HuD, HuR, TIA-1, TIAL1
3
QKI, Sam68, SLM-1, SLM-2 1
SF1 1 1 CCHC
FMRP 2
Nova-1, Nova-2 3
KSRP 4
ZRANB2 2 RanBP2
MBNL1 4 C3H1
YB-1 1 CSD
SAP155 11 HEAT repeats
RRM, RNA Recognition Motif; KH, K homology; CCHC, Cys-Cys-His-Cys; RanBP2, Ran-binding protein 2; PWI, Pro-Trp-Ile; C2H2,
Cys-Cys-His-His; G-patch, Glycine rich; SAP, SAF-A/B, Acinus and PIAS; C3H1, Cys-Cys-Cys-His; HEAT, Huntingtin, EF3, PP2A, TOR1;
CSD, cold-shock domain.
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sequences that facilitate exon deﬁnition, like exonic
splicing enhancer and intronic splicing silencer motifs.
Following the same criteria, we similarly assigned a
negative score (1 . . .10) to the target sequences that
facilitate intron deﬁnition, that is exonic splicing silencer
and intronic splicing enhancer motifs. High absolute
scores correspond to high RNA-binding afﬁnity, and
hence sequence elements with a score of +10 and 10
show the greatest afﬁnity for the SF facilitating exon
and intron deﬁnition, respectively. Obviously, our
scoring system does not represent accurately the binding
site afﬁnity because there are several factors, other than
sequence, inﬂuencing the RNA–protein binding, like
RNA secondary structure, competition or cooperation
of other proteins and other cellular physical–chemical
conditions. However, the score could provide an indica-
tion on how the context affects the binding when a motif
binds the same factor with different scores in different
contexts. The score might be also useful to train prediction
algorithms or to explain the ratio among splicing isoforms
as outcome of a binding competition between SFs.
We included in the database information on the splicing
activity (exon deﬁnition or intron deﬁnition) of the bound
SF for each RNA-binding site, as some SFs promote exon
inclusion, some promote exon skipping and others
promote both the events according to the genetic or
cellular context. Table 2 shows our data about SF
activities. In particular, SR proteins are known to possess
exon deﬁnition activity, but our data show that in rare
cases, they can promote exon skipping. Even SRp54
seems to have only intron deﬁnition activity, although
this is claimed on the basis of only one piece of evidence.
Analogously, hnRNPs have intron deﬁnition activity, but
in rare cases, they can also exhibit exon deﬁnition activity.
The distribution of the collected binding and no-binding
sites (Table 3) highlights the fact that for some factors,
only few binding sites are available. For example, for
ESRP1, ESRP2, hnRNP A0, hnRNP D0, hnRNP G,
hnRNP J, hnRNP M, QKI, RBM25, SAP155, SLM-1,
SRm160 and SRp54, only one binding site is known. In
this case, it is unfeasible to build a model of binding pref-
erence to be used in binding site predictions. Similarly, the
lack of conditional- and no-binding motifs makes hard the
deﬁnition of models with adequate speciﬁcity.
Furthermore, starting from their genomic coordinates,
we connected SpliceAid-F binding sites to the ‘Transcript
View’ section of the ASPicDB database (30,31) to show
where the motifs lie and to correlate them with the
presence of other regulatory elements and exon/intron
boundaries. For example, the presence of a binding site
for a splicing silencer in an exon can explain exon skipping
in some transcripts of ASPicDB.
Similar databases
We previously introduced SpliceAid (14) and SpliceAid 2
(15), database-driven tools for the prediction of splicing
binding sites in user-submitted sequences by exact
matching search. These tools are being used by researchers
studying functional effects of gene polymorphisms (32) or
mutations (33), as they predict whether these variations
can affect the splicing process by altering the binding
between SFs and pre-mRNA. SpliceAid-F is instead a dif-
ferent resource, consisting of a database collecting infor-
mation about SFs, such as their expression, their
orthologous genes and proteins, the associated diseases,
interacting proteins and chemicals, RNA-binding
domains and interacting and not-interacting RNAs. This
information repository has been devised for researchers
who study the splicing machinery and its functions, and
bioinformaticians who want to develop new and more
accurate binding site prediction tools.
Another repository of information on the activity of
RNA-binding proteins is the RNA-Binding Protein
DataBase (RBPDB) (34) (http://rbpdb.ccbr.utoronto.ca/
index.php). Like RBPDB, SpliceAid-F collects data
about RNA-binding proteins and their protein domains,
but the latter is speciﬁcally designed for human SFs.
Moreover, SpliceAid-F lists many other types of informa-
tion about splicing proteins. We have collected only ex-
perimental sites, whereas RBPDB does not distinguish
single motifs from consensus sequences. SpliceAid-F
collects all known binding sites for each SF, their
genomic coordinates, the corresponding gene region and
its splicing activity. SpliceAid-F contains about four times
more splicing RNA target sites than RBPDB (i.e. 2590 in
SpliceAid-F v1.0 versus 606 in RBPDB v2.1). Finally, ex-
perimentally validated no-binding sites are only collected
in SpliceAid-F.
Table 2. The activity of some splicing proteins is context dependent
Activity SR proteins hnRNP proteins Other proteins
Exon deﬁnition 9G8, HTra2a, HTra2b1,
SRm160, SRp55, SRp75
ESRP1, ESRP2, Nova-1,
Nova-2, SLM-1, SLM-2
Mainly exon deﬁnition SC35, SF2/ASF, SRp20,
SRp30c, SRp38, SRp40
ETR-3, FMRP, RBM4, Sam68,
TIA-1, TIAL1, YB-1
Mainly intron deﬁnition hnRNP F, H1, H2, H3, I (PTB), L, Q Fox-1, Fox-2, MBNL1
Intron deﬁnition SRp54 hnRNP A0, A1, A2/B1, A3, C, C1, C2, D,
D0, DL, E1, E2, G, J, K, LL,
M, P, U, nPTB
CUG-BP1, DAZAP1, HuB, HuC,
HuD, HuR, KSRP, PSF, QKI,
RBM25, RBM5, SAP155, SF1,
TDP43, ZRANB2
Exon deﬁnition: the proteins of this class have been shown so far to contribute exclusively to exon retention in mature transcripts. Mainly exon
deﬁnition: usually these proteins promote exon retention, but in rare contexts might promote exon skipping. Mainly intron deﬁnition: proteins mostly
causing exon skipping. Intron deﬁnition: proteins causing exon skipping in all contexts found.
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USING SpliceAid-F
The user can download the entire database from the
Home page or query the database by the Search interface.
Search interface
The user can search information about a speciﬁc SF by
selecting its protein name in the ﬁeld ‘Splicing Factor’, its
encoding-gene name or symbol by the ﬁeld ‘Gene’, its
target genes, its splicing activity, the chromosome or the
speciﬁc gene region where the binding site lies and the site
length. Moreover, users can search heterologous target
sequences bound from human SFs by selecting the
organism name from the ‘SF binding site in’ list. Also,
the search criteria can be combined.
SF results
After search, the result page lists the SFs that comply with
the request. For each SF, we give back the ofﬁcial name
and synonyms of its encoding gene, the orthologous genes
and proteins, the UniProt ID, the type of RNA-binding
domain(s), a list of interacting proteins and chemicals,
links to expression data, the disease associated with the
SF alteration (if available) and links to CLIP-Seq data.
Binding site and no-binding site results
Binding data are as follows: experimentally assessed
binding and no-binding sites and other experimental in-
formation such as name, ID and region of the gene where
the site lies, coordinates of the target site, the type of the
performed binding assay and splicing assay, the cell or
tissue context, the related reference (PubMed ID), the
publication year and the link to the ASPicDB. Because
the splicing activity of a factor depends also on the gene
context to which the target site belongs, for each binding
site, we report also the speciﬁc splicing activity in terms of
exon deﬁnition or intron deﬁnition. Other columns show
the known diseases associated with a binding site alter-
ation, a score meaning the binding strength.
The user can export the results in a tab-delimited plain
text ﬁle or further ﬁlter the results.
CONCLUSIONS
SpliceAid-F collects into a unique resource several hetero-
geneous information about splicing regulatory proteins,
their binding sites and context-speciﬁc activity. To our
knowledge, it is the only database collecting also
no-binding sites. Because SpliceAid-F is the most speciﬁc
and comprehensive database on human RNA splicing, it
may be a reference tool for researchers studying splicing or
mutations affecting splicing. In particular, our data may
help to explain the observed splicing patterns as well as the
effect of mutations, as mutations located in functional
regulatory elements may generate aberrant and possibly
pathological splicing patterns.
Moreover, our comprehensive collection of all experi-
mental data available can be helpful also for the design of
algorithms for RNA-binding site predictions. Including
no-binding sites permits the training of machine learning
Table 3. Distribution of the sites collected in SpliceAid-F, reporting
the number of binding sites, including conditional- and no-binding
sites, which have been shown unable to bind a splicing factor in
some or any conditions, respectively
Splicing
factor
Binding
sites
Conditional-binding
sites
No-binding
sites
9G8 70 1 29
CUG-BP1 42 3 32
DAZAP1 12 0 3
ESRP1 1 0 1
ESRP2 1 0 1
ETR-3 31 4 36
FMRP 43 4 4
Fox-1 12 0 2
Fox-2 13 0 3
hnRNP A0 1 0 0
hnRNP A1 143 17 39
hnRNP A2/B1 42 1 8
hnRNP A3 2 0 1
hnRNP C 21 7 13
hnRNP C1 11 2 19
hnRNP C2 10 0 16
hnRNP D 29 2 14
hnRNP D0 1 0 0
hnRNP DL 34 0 0
hnRNP E1 43 17 14
hnRNP E2 39 13 23
hnRNP F 67 8 26
hnRNP G 1 0 0
hnRNP H1 85 8 45
hnRNP H2 101 8 42
hnRNP H3 60 8 44
hnRNP I (PTB) 129 13 53
hnRNP J 1 0 12
hnRNP K 58 15 13
hnRNP L 172 4 9
hnRNP LL 13 0 2
hnRNP M 1 0 3
hnRNP P (TLS) 16 4 8
hnRNP Q 10 0 7
hnRNP U 19 3 0
HTra2a 7 0 3
HTra2b1 20 1 14
HuB 44 0 1
HuC 2 0 2
HuD 51 6 5
HuR 72 25 26
KSRP 22 2 7
MBNL1 92 11 34
Nova-1 25 4 18
Nova-2 12 4 9
nPTB 3 0 1
PSF 32 0 7
QKI 1 0 0
RBM25 1 0 1
RBM4 8 0 2
RBM5 7 0 2
Sam68 16 0 5
SAP155 1 0 0
SC35 172 5 47
SF1 24 1 5
SF2/ASF 248 15 52
SLM-1 1 0 0
SLM-2 6 0 0
SRm160 1 0 0
SRp20 74 0 23
SRp30c 25 9 6
SRp38 10 0 0
SRp40 68 7 27
SRp54 1 0 0
SRp55 64 7 24
SRp75 8 0 18
TDP43 22 1 8
TIA-1 39 2 7
TIAL1 37 2 2
YB-1 21 1 14
ZRANB2 19 0 4
Total 2590 245 896
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algorithms for the prediction of binding sites in a sensitive
and speciﬁc manner.
Protein interaction data permits to obtain a better
understanding of the crosstalk among the splicing machin-
ery and other pathways. These connections, in turn, might
highlight the effect of external stimuli or different cellular
conditions on splicing regulation.
SpliceAid-F will be continuously updated with quar-
terly releases.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1.
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